Company page

Seikagaku Corporation

Seikagaku Corporation, traded under the ticker 4548, is a public company based in Japan with a market capitalization of approximately 276.5 million USD. The company specializes in the development and manufacturing of pharmaceuticals, particularly focusing on treatments for osteoarthritis and other musculoskeletal disorders. Seikagaku is committed to advancing healthcare through innovative solutions and research in the biopharmaceutical sector.